Exogenous S100A8 suppresses the PDGF-induced migration of airway smooth muscle cells.
Blockade of cell membrane receptor RAGE abolishes the anti-migration effect of S100A8.
S100A8 may be an effective therapeutic candidate for the airway remodeling in chronic airway diseases.